InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application...
InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application...
Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed...
Wockhardt Limited has announced a major boost to the New Drug Discovery program in Anti-Infective research when two of its...
Law enforcement authorities from Austria, Belgium, Cyprus, France, Hungary, Slovakia, Spain and the United Kingdom, supported by Europol and Eurojust,...
US-based biotech firm Senesco Technologies has completed patient enrolment in its ongoing Phase Ib/IIa clinical trial of SNS01-T to treat...
The UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment...
The US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa...
DPx Holdings BV has announced that it has reached a definitive agreement to buy all the shares of Gallus BioPharmaceuticals,...
India-based Venus Remedies has signed a collaborative agreement with Teva Canada for an anti-cancer drug, which is under patent protection...
Cardiome Pharma Corp. today announced that its subsidiary, Correvio International SÃ rl, has entered into an agreement with Eurolab Especialidades Medicinales...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.